NASDAQ:DFFN
Delisted
Diffusion Pharmaceuticals Inc Stock News
$5.87
+0 (+0%)
At Close: Nov 28, 2023
Diffusion Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update
09:01pm, Monday, 14'th Nov 2022 GlobeNewswire Inc.
CHARLOTTESVILLE, Va., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), a biopharmaceutical company developing novel therapies t
Diffusion Pharmaceuticals Sees Significant Progress in its Strategic Review Process
11:30am, Monday, 14'th Nov 2022 GlobeNewswire Inc.
Diffusion in Active Bidding Stage and Encouraged by Response to the Strategic Review Process
Diffusion Pharmaceuticals Announces Strategic Review Process to Evaluate Value-Enhancing Alternatives including Opportunities to Better Leverage TSC
10:30am, Tuesday, 25'th Oct 2022 GlobeNewswire Inc.
Benzinga's Top Ratings Upgrades, Downgrades For August 16, 2022
02:12pm, Tuesday, 16'th Aug 2022 Benzinga
Upgrades
Craig-Hallum upgraded the previous rating for CalAmp Corp (NASDAQ:CAMP) from Hold to Buy. In the first quarter, CalAmp showed an EPS of $0.10, compared to $0.08 from the year-ago quarter. At
Diffusion Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update
10:48pm, Thursday, 11'th Aug 2022 GlobeNewswire Inc.
• Aligned with FDA on Design of Phase 2 GBM Trial of TSC; Initiation Expected by End of 2022• Reported Positive Effects in TSC Altitude Trial• Ended Quarter with $28.5 million in Cash, Cas
Diffusion Pharmaceuticals Announces Positive Effects in Altitude Trial
11:30am, Thursday, 23'rd Jun 2022 GlobeNewswire Inc.
CHARLOTTESVILLE, Va., June 23, 2022 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) (“Diffusion” or the “Company”), a biopharmaceutical company developing therapies that en
Diffusion Pharmaceuticals to Present at H.C. Wainwright Global Investment Conference
07:30am, Tuesday, 17'th May 2022
CHARLOTTESVILLE, Va., May 17, 2022 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), a biopharmaceutical company developing novel therapies that
Diffusion Pharmaceuticals Regains Compliance With Nasdaq Listing Requirements
11:20am, Wednesday, 04'th May 2022 GlobeNewswire Inc.
CHARLOTTESVILLE, Va., May 04, 2022 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), a biopharmaceutical company developing novel therapies th
5 Stocks Halted In Tuesday's Session
06:01pm, Tuesday, 19'th Apr 2022
A circuit breaker is an automatic, temporary trading halt on specific securities when the underlying stock is experiencing times of high volatility. It is a measure to help restore and bring order to
Diffusion Pharmaceuticals (DFFN) Stock: 1-For-50 Reverse Stock Split Announced
08:28pm, Monday, 18'th Apr 2022
Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) announced it will effect a 1-for-50 reverse stock split of its common stock. These are the details.
Diffusion Pharmaceuticals Announces 1-for-50 Reverse Stock Split as Part of Nasdaq Compliance Plan
01:20pm, Monday, 18'th Apr 2022 GlobeNewswire Inc.
Split Expected to be Effective for Trading Purposes as of Market Open on April 19, 2022 Split Expected to be Effective for Trading Purposes as of Market Open on April 19, 2022
Diffusion Pharmaceuticals' 50-For-1 Stock Split Will Go Into Effect Tomorrow
10:52am, Monday, 18'th Apr 2022
Diffusion Pharmaceuticals Inc (NASDAQ: DFFN) will effect a 1-for-50 reverse stock split of its common stock. The reverse stock split is expected to become effective and commence trading on a post
Why Diffusion Pharmaceuticals Shares Are Falling
09:48am, Monday, 18'th Apr 2022
Diffusion Pharmaceuticals Inc (NASDAQ: DFFN) shares are trading lower by 20.83% at $0.21 after the company announced a 1-for-50 reverse stock split. Diffusion Pharmaceuticals says the reverse stock sp
Diffusion Pharmaceuticals Completes Dosing in Altitude Trial
11:20am, Monday, 11'th Apr 2022 GlobeNewswire Inc.
Topline data expected within two months
Diffusion Pharmaceuticals Announces New Date for Previously Announced Special Meeting of Stockholders
11:20am, Friday, 08'th Apr 2022 GlobeNewswire Inc.
• Special Meeting of Stockholders Rescheduled to Monday, April 18, 2022 at 9:00 a.m. E.T.• No Change to Meeting Location, Record Date, or Proposals to Be Voted Upon
